Tom van den Bosch

Standard PhD Candidate, AII - Immunology Affiliatie UvA Standard PhD Candidate, Amsterdam Gastroenterology Endocrinology Metabolism Standard PhD Candidate, CCA - Cancer biology and immunology Research Associate, Clinical Hematology

Specialization

Mathematical Modelling of Biological processes

Focus of research

Modelling of intra-tumor heterogeneity in colon cancer.

Latest publications

Molecular characterization of colorectal cancer related peritoneal metastatic disease
Lenos, K. J., Bach, S., Ferreira Moreno, L., ten Hoorn, S., Sluiter, N. R., Bootsma, S., Vieira Braga, F. A., Nijman, L. E., van den Bosch, T., Miedema, D. M., van Dijk, E., Ylstra, B., Kulicke, R., Davis, F. P., Stransky, N., Smolen, G. A., Coebergh van den Braak, R. R. J., IJzermans, J. N. M., Martens, J. W. M., Hallam, S., & 20 othersBeggs, A. D., Kops, G. J. P. L., Lansu, N., Bastiaenen, V. P., Klaver, C. E. L., Lecca, M. C., el Makrini, K., Elbers, C. C., Dings, M. P. G., van Noesel, C. J. M., Kranenburg, O., Medema, J. P., Koster, J., Koens, L., Punt, C. J. A., Tanis, P. J., de Hingh, I. H., Bijlsma, M. F., Tuynman, J. B. & Vermeulen, L., 1 Dec 2022, In: Nature communications. 13, 1, 4443.
Research output: Contribution to journal › Article › Academic › peer-review
Copy number heterogeneity identifies ER+ breast cancer patients that do not benefit from adjuvant endocrine therapy
van den Bosch, T., Rueda, O. M., Caldas, C., Vermeulen, L. & Miedema, D. M., 19 Oct 2022, In: British journal of cancer. 127, 7, p. 1332-1339 8 p.
Research output: Contribution to journal › Article › Academic › peer-review
Chromosomal Instability, Selection and Competition: Factors That Shape the Level of Karyotype Intra-Tumor Heterogeneity
van den Bosch, T., Derks, S. & Miedema, D. M., 1 Oct 2022, In: Cancers. 14, 20, 4986.
Research output: Contribution to journal › Review article › Academic › peer-review
All publications

Tom van den Bosch

Specialization

Focus of research

Molecular characterization of colorectal cancer related peritoneal metastatic disease

Copy number heterogeneity identifies ER+ breast cancer patients that do not benefit from adjuvant endocrine therapy

Chromosomal Instability, Selection and Competition: Factors That Shape the Level of Karyotype Intra-Tumor Heterogeneity

We use cookies